Pulmonary drug delivery with vesicles comprising non-ionic surfactants

Katharine Carter (Inventor), Alexander Mullen (Inventor), Valerie Ferro (Inventor)

Research output: Patent

Abstract

The present invention relates to formulations for delivery of drugs to the respiratory tract, especially the lungs, as well as improved methods of treating subjects suffering or predisposed to suffering from lung conditions/diseases. The invention is particularly directed to lung cancer treatment using, for example, cytotoxic platinum based drugs.
LanguageEnglish
Patent numberWO/2009/156706
IPCPCT/GB2009/000539
Publication statusPublished - 30 Dec 2009

Fingerprint

Drug Compounding
Platinum
Surface-Active Agents
Respiratory System
Lung Diseases
Lung Neoplasms
Lung
Pharmaceutical Preparations

Keywords

  • pulmonary
  • drug delivery
  • vesicles
  • non-ionic surfactants

Cite this

@misc{8b09a3746c7b4c6aa54cb118af8ecc1d,
title = "Pulmonary drug delivery with vesicles comprising non-ionic surfactants",
abstract = "The present invention relates to formulations for delivery of drugs to the respiratory tract, especially the lungs, as well as improved methods of treating subjects suffering or predisposed to suffering from lung conditions/diseases. The invention is particularly directed to lung cancer treatment using, for example, cytotoxic platinum based drugs.",
keywords = "pulmonary , drug delivery, vesicles, non-ionic surfactants",
author = "Katharine Carter and Alexander Mullen and Valerie Ferro",
year = "2009",
month = "12",
day = "30",
language = "English",
type = "Patent",
note = "WO/2009/156706 ; PCT/GB2009/000539",

}

TY - PAT

T1 - Pulmonary drug delivery with vesicles comprising non-ionic surfactants

AU - Carter, Katharine

AU - Mullen, Alexander

AU - Ferro, Valerie

PY - 2009/12/30

Y1 - 2009/12/30

N2 - The present invention relates to formulations for delivery of drugs to the respiratory tract, especially the lungs, as well as improved methods of treating subjects suffering or predisposed to suffering from lung conditions/diseases. The invention is particularly directed to lung cancer treatment using, for example, cytotoxic platinum based drugs.

AB - The present invention relates to formulations for delivery of drugs to the respiratory tract, especially the lungs, as well as improved methods of treating subjects suffering or predisposed to suffering from lung conditions/diseases. The invention is particularly directed to lung cancer treatment using, for example, cytotoxic platinum based drugs.

KW - pulmonary

KW - drug delivery

KW - vesicles

KW - non-ionic surfactants

UR - http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2009156706&recNum=266&docAn=GB2009000539&queryString=RPA:(marks%2520and%2520clerk%2520glasgow)%2520&maxRec=801

M3 - Patent

M1 - WO/2009/156706

ER -